ATXN3 and demyelinating disease: Evidence of oligodendrocyte dysfunction has recently expanded beyond classic demyelinating diseases into neurodegenerative diseases, including ALS, Alzheimer’s disease, Huntington’s disease, and SCA3 [21,22,23,24,25,26,27,57,58,59].